9:45

Reactions from Federal Agencies

- Darrell Regier, Director, Division of Clinical Research, NIMH

- Dennis Smith, Associate Director for Medical Research, Department Veterans Affairs

- Ira Raskin, Agency for Health Care Policy and Research

10:15

Panel/Committee Discussion

11:00

BREAK

11:15

PRIVATE SECTOR FUNDING

 

Discussion Leader: Irving Fox

11:20

Funding by the Pharmaceutical/Biotechnology Industry

- Louis Lasagna, Tufts University

11:30

University/Industry Cooperative Funding Ventures

- Virginia Weldon, Monsanto Corporation

11:40

Nonprofit Sponsors

- Thomas Langfitt, Pew Charitable Trusts

11:50

Panel/Committee Discussion

12:40

LUNCH

1:30

SHARING THE COSTS OF CLINICAL RESEARCH:

I. THIRD-PARTY PAYERS

 

Discussion Leader: Karen Antman

1:40

Role of Third-Party Payment Decisions on Clinical Research

- Michael Friedman, National Cancer Institute

1:50

Blue Cross/Blue Shield

- Ralph Schafferzick, Formerly with Blue Cross/Blue Shield of California

2:00

Private Insurers

- James Mulvihill, Travelers Insurance Company

2:10

Health Maintenance Organizations

- Robert Goodman, US HealthCare, Inc.

2:20

Panel/Committee Discussion



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement